# Japan Closed System Drug Transfer Device Market > Japan Closed System Drug Transfer Device Market Research Report: Size, Share, Trend Analysis By Types (Membrane-to-membrane, Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, Air Filtration Devices), and By End-users (Hospitals & Clinics, Specialty Centers, Others) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 11.21% - **2024:** $ 60 Million - **2025:** $ 66.73 Million - **2035:** $ 193 Million - **Key Players:** Baxter International Inc (US), B. Braun Melsungen AG (DE), Cardinal Health Inc (US), Cypress Medical Products LLC (US), ICU Medical Inc (US), Merit Medical Systems Inc (US), Pall Corporation (US), Terumo Corporation (JP) **Report ID:** MRFR/Pharma/47915-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/japan-closed-system-drug-transfer-device-market-49669 --- ## Market Summary ## **Japan Closed System Drug Transfer Device Market Overview** As per MRFR analysis, the Japan Closed System Drug Transfer Device Market Size was estimated at 32.1 (USD Million) in 2023.The Japan Closed System Drug Transfer Device Market is expected to grow from 36(USD Million) in 2024 to 120 (USD Million) by 2035. The Japan Closed System Drug Transfer Device Market CAGR (growth rate) is expected to be around 11.567% during the forecast period (2025 - 2035). ### **Key Japan Closed System Drug Transfer Device Market Trends Highlighted** A greater emphasis on safety and regulatory compliance in healthcare settings is driving notable changes in the Japan [closed system drug transfer device market](../../../reports/closed-system-drug-transfer-device-market-7733). Healthcare professionals' growing awareness of the need to prevent medication exposure and contamination is a major factor driving the market. In Japan, healthcare facilities are forced to implement safer medication handling procedures due to strict laws set by the Ministry of Health, Labour, and Welfare. The market is being greatly shaped by this government effort, which is encouraging more healthcare professionals to invest in closed system medication transfer systems. Additionally, as Japanese hospitals and clinics seek to modernize their current systems and integrate new technologies that improve efficiency and safety, market prospects are growing. Manufacturers have a great chance to innovate and set their goods apart from the competition thanks to the increasing use of cutting-edge technology in medical devices, such as integration with digital monitoring systems. As healthcare professionals choose gadgets that are easier to use while meeting safety standards, recent developments show a shift towards more ergonomic and user-friendly designs. The need for safe drug transfer techniques is also being impacted by Japan's aging population, as older populations typically need medical attention more frequently. The market for closed-system drug transfer devices is anticipated to change in response to new healthcare demands and technological breakthroughs, while patient safety remains a top priority. All things considered, the market for closed-system drug transfer devices in Japan is expanding rapidly due to changes in the population, technical developments, and regulatory requirements, paving the way for improved healthcare safety in the future. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Japan Closed System Drug Transfer Device Market Drivers** ### **Increase in Oncology Cases Drive Demand for Closed System Drug Transfer Devices** Japan has witnessed a significant rise in oncology cases, which drives the demand for closed system drug transfer devices in the healthcare sector. According to the Japan National Cancer Center, there were approximately 1.04 million new cancer cases reported in 2020, and this number is projected to rise steadily. The Japanese government is emphasizing the development of advanced therapeutic techniques, and organizations like the Japanese Society of Clinical Oncology are advocating for the adoption of safety measures, including the use of closed-system drug transfer devices. The need to minimize exposure to hazardous drugs for healthcare professionals, especially in oncology units, correlates directly with the increasing number of cancer patients and the legislation advocating for safer handling procedures. In Japan's strict regulatory environment, this correlation between increased cancer incidences and safety regulation creates a promising landscape for the growth of the Japan Closed System Drug Transfer Device Market. ### **Stringent Regulatory Compliance Enhances Adoption of Safety Devices** Japan boasts a robust regulatory framework focused on safety in healthcare, particularly concerning hazardous drugs. The Pharmaceutical and Medical Devices Agency (PMDA) has set stringent guidelines for the handling of chemotherapy agents, creating a pressing need for medical facilities to adopt closed-system drug transfer devices. With the PMDA's policies mandating the use of safety equipment to protect healthcare workers and patients, hospitals and clinics are increasingly investing in closed-system solutions. Moreover, the involvement of organizations such as the Japan Hospital Association promotes awareness and compliance with these regulations, fostering growth in the Japan Closed System Drug Transfer Device Market through increased procurement of compliant equipment. ### **Technological Advancements in Drug Delivery Systems** The rapid evolution of technology within the pharmaceutical and medical industries in Japan stimulates growth in the Closed System Drug Transfer Device Market. Innovations in drug delivery mechanisms, such as improved needleless systems and advanced prefilled syringes, are enhancing user safety and efficiency. The Japanese government has invested significantly in Research and Development (R&D) initiatives, enabling companies like Terumo Corporation and Nipro Corporation to develop innovative closed systems that are more efficient and user-friendly. By 2022, these technological advancements contributed to a market worth approximately USD 15 million, setting the stage for robust growth ahead as hospitals increasingly opt for advanced systems that align with the trend of minimizing risks associated with hazardous drug handling. ## **Japan Closed System Drug Transfer Device Market Segment Insights** ### **Closed System Drug Transfer Device Market Type Insights** The Japan Closed System Drug Transfer Device Market, focusing on the Type segment, encompasses innovative technologies that ensure the safe handling of hazardous drugs. Two prominent types within this market are the Membrane-to-membrane systems and Needleless Systems, each contributing to the growth and efficiency of drug transfer processes. Membrane-to-membrane systems are designed to create a secure barrier that minimizes the risk of contamination and leakage, making them crucial for the safe administration of chemotherapy agents and other high-risk medications. This type is gaining traction owing to enhanced safety features and the ability to streamline workflows in high-pressure healthcare settings. On the other hand, Needleless Systems have revolutionized medication administration by removing the need for traditional needles, significantly reducing needle-stick injuries, and improving overall safety for healthcare professionals and patients alike. The move towards needle-free technology aligns with broader trends in healthcare focusing on minimizing risks associated with drug handling, thereby improving operational efficiency and patient outcomes. These systems play a pivotal role, particularly in Japan, as the country emphasizes high-quality healthcare standards and the protection of medical staff from occupational hazards. The Japan Closed System Drug Transfer Device Market is expected to experience robust growth driven by these types, as healthcare facilities increasingly adopt advanced solutions for safer drug delivery. This evolution will be supported by government initiatives promoting safety regulations and best practices in handling hazardous medications, further enhancing the importance of these systems in the sector. As such, both Membrane-to-membrane and Needleless Systems are essential components, continuing to shape the landscape of drug transfer technology in Japan's healthcare environment. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Closed System Drug Transfer Device Market Component Insights** The Japan Closed System Drug Transfer Device Market is significantly shaped by its Component segment, which encompasses various critical elements essential for safe drug handling. Vial Access Devices are crucial as they ensure secure and sterile access to vials, reducing the risk of contamination, while Syringe Safety Devices play a pivotal role in minimizing needlestick injuries, a major concern in healthcare facilities. Accessories, although sometimes overlooked, provide necessary auxiliary functions that enhance device efficiency and usability in clinical settings. Bag/Line Access Devices hold importance for drug delivery in intravenous therapies, ensuring that drugs are transferred without exposure to harmful agents. This Component segment collectively fosters a safer environment for both healthcare professionals and patients, driven by ongoing advancements in technology and a rising demand for effective drug transfer solutions. The growth of this sector is further stimulated by the increasing focus on patient safety and the stringent regulations surrounding drug administration techniques in Japan's healthcare industry. As these components continue to evolve, they will play an integral part in shaping the future of the Japan Closed System Drug Transfer Device Market. ### **Closed System Drug Transfer Device Market Closing Mechanism Insights** The Closing Mechanism segment of the Japan Closed System Drug Transfer Device Market plays a vital role in ensuring the safe transfer and handling of hazardous drugs. Various mechanisms, including Push to Turn Systems and Color-to-color Alignment Systems, are designed to prevent leaks and contamination, addressing stringent safety regulations in Japan's healthcare settings. The Leur Lock Systems are recognized for their robust connection methods, promoting universal compatibility and reliable performance across different equipment. Click to Lock Systems provide an intuitive locking mechanism, enhancing user convenience and reducing the chances of accidental disengagement during drug transfer. The significance of these mechanisms not only lies in their functionality but also in their ability to comply with Japan's rigorous standards for healthcare products. Emerging trends indicate a growing demand for innovative and efficient closing mechanisms as Japan continues to emphasize patient safety and medication efficacy. This trend is supported by increased awareness of the risks associated with hazardous drug handling, thus promoting the development and adoption of advanced technological solutions in the market. ### **Closed System Drug Transfer Device Market Technology Insights** The Technology segment of the Japan Closed System Drug Transfer Device Market showcases a diversified array of innovations tailored to enhance safety and efficiency in healthcare settings. Compartmentalized Devices are gaining traction due to their capacity to minimize exposure risk during drug handling, providing an essential layer of safety for healthcare professionals. Meanwhile, Diaphragm-Based Devices play a critical role by ensuring the integrity of drug transfers, efficiently preventing contamination while maintaining ease of use. Air Filtration Devices are significant in the segment as they effectively mitigate airborne risks, an increasingly important factor in hospital environments focusing on infection control. Each of these technologies contributes to a safer drug handling process, addressing the urgent need for effective solutions to reduce hazardous exposure in clinical settings. As the Japan Closed System Drug Transfer Device Market evolves, these technologies will continue to be pivotal, driving demand for higher standards of safety in pharmaceutical practices and responsiveness to regulatory requirements. ### **Closed System Drug Transfer Device Market End-user Insights** The End-users segment of the Japan Closed System Drug Transfer Device Market plays a crucial role in ensuring safe and effective medication administration in various healthcare settings. Hospitals and clinics are primary users of these devices, as they are essential for minimizing the risk of hazardous drug exposure and maintaining sterile environments. With a growing patient population and increasing instances of chronic diseases, the demand for specialized services in hospitals and clinics is expected to rise, contributing significantly to the market. Specialty centers, which focus on specific treatment areas such as oncology and compounding, are also critical End-users, as they require advanced drug transfer technologies to handle high-risk medications safely. The importance of these centers lies in their ability to cater to unique patient needs and enhance treatment outcomes while ensuring safety standards. Other healthcare facilities, such as home healthcare services and outpatient clinics, increasingly recognize the importance of closed system drug transfer devices to protect healthcare workers and patients alike. As the healthcare landscape in Japan evolves, the increased focus on patient safety and regulatory compliance will drive the growth of the Japan Closed System Drug Transfer Device Market, with End-users adapting to the latest technological advancements to enhance their service delivery. ## **Japan Closed System Drug Transfer Device Market Key Players and Competitive Insights** The Japan Closed System Drug Transfer Device Market is characterized by an increasingly competitive landscape driven by a heightened focus on safety and efficacy in drug delivery systems. As healthcare providers strive to minimize the risks associated with hazardous drug exposure, the demand for closed system drug transfer devices (CSTD) is on the rise. This sector showcases a variety of players offering innovative solutions designed to meet regulatory standards and safeguard healthcare professionals and patients from potential contamination. With a landscape in flux due to technological advancements and regulatory developments, market participants are establishing their presence through strategic partnerships, product innovations, and targeted marketing initiatives. As a result, companies must actively monitor competitors' operations and adapt their strategies to remain relevant and gain market share in this evolving market. ### **C.R. Bard** C.R. Bard has established a significant footprint in the Japan Closed System Drug Transfer Device Market, showcasing its strengths in design and manufacturing. The company is renowned for its commitment to producing high-quality, reliable CSTDs that address the unique needs of the Japanese healthcare system. C.R. Bard's robust R&D capabilities allow it to innovate continuously, ensuring that its products meet the high standards expected in Japan, where regulatory compliance and safety are paramount considerations. The company also benefits from a well-structured distribution network, allowing for effective penetration into hospitals and healthcare facilities. Its established reputation for excellence has positioned C.R. Bard as a trusted provider of closed systems, enabling it to maintain a competitive edge as the market grows. ### **Smiths Medical** Smiths Medical has also secured a reputable position within the Japan Closed System Drug Transfer Device Market, distinguished by its advanced technology and comprehensive product offerings designed for medication administration and patient safety. The company provides a range of key products, including various CSTD options that prioritize user safety and handling efficiency. Smiths Medical's continuous focus on product development aligns with Japan's evolving regulatory landscape, showcasing its strengths in innovation and responsiveness to market needs. Moreover, Smiths Medical has entered into strategic partnerships and potential mergers and acquisitions to enhance its market presence, allowing it to expand its influence across the region. With a dedicated team focused on the unique requirements of the Japanese market, Smiths Medical continues to solidify its commitment to improving outcomes in healthcare, thus positioning itself effectively against competitors in this key segment. ### **Key Companies in the Japan Closed System Drug Transfer Device Market Include** ## **Japan Closed System Drug Transfer Device Market Developments** Recent developments in the Japan Closed System Drug Transfer Device Market indicate significant advancements and focus on safety and efficiency in medical facilities. Companies like C.R. Bard, Baxter International, and West Pharmaceutical Services have been enhancing their product offerings to meet the growing demand for safety-engineered devices. Notably, in June 2023, Vygon announced a strategic collaboration with a leading Japanese pharmaceutical company to drive innovation in drug transfer safety, showcasing the increasing importance of local partnerships. Moreover, in July 2022, Thermo Fisher Scientific expanded its presence in Japan by opening a new facility focused on production innovations in drug delivery systems, reflecting the market's growth potential. In terms of mergers and acquisitions, there are reports of C.R. Bard considering strategic acquisitions to bolster its market share in Japan, although no specific transactions have been finalized as of October 2023. The increasing focus on patient safety regulations and the rising incidence of oncology treatments are contributing to the overall market valuation growth, positioning Japan as a pivotal region for investments in closed-system drug transfer technologies. The market is expected to continue evolving with the need for improved healthcare solutions. ## **Japan Closed System Drug Transfer Device Market Segmentation Insights** ### **Closed System Drug Transfer Device Market Type Outlook** ### **Closed System Drug Transfer Device Market Component Outlook** ### **Closed System Drug Transfer Device Market Closing Mechanism Outlook** ### **Closed System Drug Transfer Device Market Technology Outlook** ### **Closed System Drug Transfer Device Market End-usersOutlook** ## Market Drivers ### Rising Demand for Safety Protocols The increasing emphasis on safety protocols within healthcare settings is driving the closed system-drug-transfer-device market. In Japan, healthcare facilities are prioritizing the protection of healthcare workers from hazardous drug exposure. This trend is reflected in the adoption of closed system-drug-transfer devices, which are designed to minimize the risk of contamination and exposure. As a result, the market is projected to grow at a CAGR of approximately 8% over the next five years. The heightened awareness of occupational safety is likely to propel investments in advanced drug transfer technologies, thereby enhancing the overall market landscape. ### Focus on Infection Control Measures The heightened focus on infection control measures within healthcare facilities is driving the closed system-drug-transfer-device market. In Japan, hospitals are increasingly adopting stringent protocols to prevent healthcare-associated infections, which has led to a surge in the use of closed system-drug-transfer devices. These devices are designed to reduce the risk of contamination during drug preparation and administration. The market is projected to grow at a rate of approximately 7% as healthcare providers recognize the importance of infection control in enhancing patient outcomes. This trend underscores the critical role of closed system-drug-transfer devices in maintaining high standards of safety in healthcare. ### Technological Integration in Healthcare The integration of advanced technologies in healthcare is a key driver for the closed system-drug-transfer-device market. In Japan, the rise of automation and digital solutions in medical practices is fostering the adoption of sophisticated drug transfer systems. These devices are increasingly equipped with features such as real-time monitoring and data analytics, which enhance their functionality and safety. The market is projected to expand by approximately 9% as healthcare facilities seek to leverage technology for improved efficiency and safety in drug handling. This trend indicates a shift towards more reliable and efficient healthcare delivery systems. ### Aging Population and Increased Healthcare Needs Japan's aging population is contributing to the growing demand for healthcare services, thereby impacting the closed system-drug-transfer-device market. As the elderly population increases, there is a corresponding rise in the need for safe and effective drug administration methods. The market is expected to grow by about 6% as healthcare providers seek to accommodate the complex medication regimens often required by older patients. This demographic shift necessitates the implementation of closed system-drug-transfer devices to ensure safety and efficacy in drug delivery, highlighting the importance of these devices in modern healthcare. ### Government Initiatives for Healthcare Improvement Government initiatives aimed at improving healthcare quality and safety are significantly influencing the closed system-drug-transfer-device market. In Japan, the Ministry of Health, Labour and Welfare has implemented various programs to promote the use of safer drug handling practices. These initiatives are expected to increase the adoption of closed system-drug-transfer devices across hospitals and clinics. The market is anticipated to witness a growth rate of around 7% as healthcare providers align with these government mandates. Such policies not only enhance patient safety but also encourage the integration of innovative technologies in drug administration. ## Future Outlook The [Closed System Drug Transfer Device Market](https://www.marketresearchfuture.com/reports/closed-system-drug-transfer-device-market-7733) in Japan is projected to grow at 11.21% CAGR from 2025 to 2035, driven by increasing safety regulations and technological advancements. **New opportunities:** - Development of integrated software solutions for device management. - Expansion into home healthcare markets with portable devices. - Partnerships with hospitals for customized training programs. By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs. ## Segment Insights ### By Type: Membrane-To-Membrane Systems (Largest) vs. Needleless Systems (Fastest-Growing) The Japan closed system drug transfer device market reveals a competitive landscape among key segment values. Membrane-To-Membrane Systems currently hold the largest market share, driven by their reliability and effectiveness in ensuring safe drug transfers. In contrast, Needleless Systems are emerging rapidly, appealing to healthcare providers seeking to improve convenience and reduce the risk of needlestick injuries. Growth trends in this segment indicate a significant shift towards safety-oriented solutions. The demand for Needleless Systems is increasing due to stringent regulations and a growing emphasis on patient safety. Additionally, advancements in technology and product innovation are propelling the adoption of these systems, making them a preferred choice for hospitals and clinics aiming to enhance operational efficiency and patient outcomes. Membrane-To-Membrane Systems (Dominant) vs. Needleless Systems (Emerging) Membrane-To-Membrane Systems are characterized by their established presence in the Japan closed system-drug-transfer-device market, primarily known for their efficiency in preventing contamination during drug transfers. This system's reliability has made it a dominant choice among healthcare professionals. On the other hand, Needleless Systems represent an emerging segment gaining traction due to their ability to minimize risk and improve safety protocols. These systems are increasingly being integrated into clinical practices, offering healthcare providers innovative solutions that meet the growing demand for safer and more efficient drug administration methods. ### By Component: Syringe Safety Devices (Largest) vs. Vial Access Devices (Fastest-Growing) In the Japan closed system-drug-transfer-device market, the distribution of market share among segment values reveals that Syringe Safety Devices hold the largest portion, driven by their essential role in ensuring safe medication delivery. Vial Access Devices, while currently smaller in share, are gaining momentum as they are increasingly integrated into various healthcare applications, showcasing an evolving landscape within the sector. Growth trends in this segment are significantly influenced by stringent regulations and an increasing focus on patient safety. The rise in surgical procedures and medical innovations further propels demand for these devices. Emerging technologies and advancements in design also contribute to the appeal of Vial Access Devices, making them a fast-growing aspect of the market, particularly in the context of safety and efficiency demands in drug transfer mechanisms. Syringe Safety Devices: Dominant vs. Vial Access Devices: Emerging Syringe Safety Devices dominate the market due to their critical role in reducing needlestick injuries and ensuring safe drug administration, thus appealing to healthcare facilities prioritizing staff and patient safety. Their established presence and widespread adoption make them integral to many health institutions. In contrast, Vial Access Devices are emerging as significant players, particularly as innovations enhance their usability and safety features. Improvements in design and functionality are making these devices more appealing to healthcare professionals. As hospital protocols evolve to favor closed systems, the demand for Vial Access Devices is expected to rise, positioning them as a pivotal segment in the market. ### By Closing Mechanism: Push To Turn System (Largest) vs. Click-To Lock System (Fastest-Growing) The distribution of market share for closing mechanisms in the Japan closed system-drug-transfer-device market reveals a competitive landscape. The Push To Turn System currently commands the largest share, favored for its reliability and ease of use. In contrast, the Click-To Lock System is gaining traction, driven by an increasing demand for safety and effectiveness in drug transfer processes. The Color-To-Color Alignment System and Luer Lock Systems also play significant roles, yet their market presence is overshadowed by these two dominant mechanisms. Growth trends for this segment are shaped by innovation and regulatory demands. The rapid adoption of advanced technologies in drug delivery is propelling the Click-To Lock System's growth, as healthcare providers seek solutions that enhance safety and efficiency. The increasing focus on minimizing contamination and maximizing user experience drives the shift toward more sophisticated mechanisms, ensuring that market dynamics remain favorable for these evolving solutions. Push To Turn System (Dominant) vs. Click-To Lock System (Emerging) The Push To Turn System remains the dominant player in the Japan closed system-drug-transfer-device market, known for its robust design that ensures secure closures, minimizing the risk of contamination during drug transfer. Its widespread acceptance is a testament to its reliability in healthcare settings. Conversely, the Click-To Lock System is emerging as a competitive alternative, favored for its user-friendly operation and innovative design which enhances safety. As healthcare professionals become more aware of the importance of secure drug transfer methods, the Click-To Lock System is expected to capture a more significant portion of the market, appealing to those prioritizing both functionality and safety. ### By Technology: Compartmentalize Devices (Largest) vs. Diaphragm-Based Devices (Fastest-Growing) In the Japan closed system-drug-transfer-device market, Compartmentalize Devices hold the largest share among the various technology segments. This category has established itself as a preferred choice due to its effectiveness in ensuring safe drug transfer practices, thereby dominating market dynamics. Diaphragm-Based Devices, while smaller in market share, are quickly gaining traction and appeal due to their innovations that enhance reliability and efficiency in drug handling. Recent growth trends indicate a robust shift towards more advanced technologies designed to improve safety and efficiency. The rising demand for safer drug transfer solutions, driven by increased regulatory scrutiny and a growing emphasis on minimizing contamination risks, is propelling Diaphragm-Based Devices forward as the fastest-growing segment. The technological advancements in this space are expected to keep the momentum strong, attracting significant investment and interest. Technology: Compartmentalize Devices (Dominant) vs. Diaphragm-Based Devices (Emerging) Compartmentalize Devices are recognized for their robust framework in securing and compartmentalizing drugs for safe transit, making them the dominant choice among healthcare providers. Their design not only ensures contamination prevention but also supports efficient drug transfer mechanisms. On the other hand, Diaphragm-Based Devices are emerging as key players in the market. They offer unique benefits like enhanced sterilization capabilities and ease of use, which are critical in environments with stringent safety protocols. This segment is rapidly evolving with innovative designs that are responding to healthcare demands, indicating a promising future. Their growth is bolstered by technological improvements and a rising awareness of infection control, making them increasingly attractive in the evolving landscape of drug transfer solutions. ### By End User: Hospitals & Clinics (Largest) vs. Specialty Centers (Fastest-Growing) In the Japan closed system-drug-transfer-device market, the distribution of market share among end users is notably skewed towards hospitals and clinics, which command the largest portion. This segment is characterized by their extensive requirement for drug transfer safety and efficiency, leading to a significant adoption of closed system drug transfer devices. Specialty centers, although smaller in share, are rapidly increasing their utilization due to their niche services and specialized patient needs, positioning them as an emerging player in this market. Growth trends indicate that hospitals and clinics will continue to be the primary market drivers, but specialty centers are expected to grow at a faster rate. The increasing number of outpatient procedures and the rising prevalence of chronic diseases are pushing specialty centers to enhance their operational capabilities with advanced drug transfer technologies. This dual growth in both segments reflects a dynamic market adapting to changing healthcare demands in Japan. Hospitals & Clinics (Dominant) vs. Specialty Centers (Emerging) The hospitals and clinics segment represents the dominant force in the Japan closed system-drug-transfer-device market. These institutions prioritize patient safety and regulatory compliance, leading to widespread adoption of innovative drug transfer solutions. With substantial budgets and a focus on advanced healthcare delivery, hospitals are often the first to integrate new technologies. On the other hand, specialty centers are emerging as vital contributors to this market, driven by specific medical practices requiring specialized care. Their agility in adopting cutting-edge technologies allows them to respond swiftly to market demands, making them an increasingly relevant player. This evolving landscape highlights the need for manufacturers to cater to varying requirements across these end user segments. ## Competitive Benchmarking The closed system-drug-transfer-device market in Japan is characterized by a competitive landscape that is increasingly shaped by innovation, regulatory compliance, and the demand for safety in drug handling. Key players such as Baxter International Inc (US), B. Braun Melsungen AG (DE), and Terumo Corporation (JP) are actively pursuing strategies that emphasize technological advancements and partnerships to enhance their market positions. Baxter International Inc (US) focuses on developing advanced drug delivery systems, while B. Braun Melsungen AG (DE) emphasizes sustainability and eco-friendly practices in its product offerings. Terumo Corporation (JP) is leveraging its strong local presence to expand its product range and improve customer engagement, collectively shaping a dynamic competitive environment. In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. The market structure appears moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This competitive structure allows for a diverse range of products and innovations, fostering a healthy environment for growth and development. In October 2025, Baxter International Inc (US) announced the launch of a new closed system drug transfer device designed to enhance safety and efficiency in drug preparation. This strategic move is likely to strengthen Baxter's position in the market by addressing the growing concerns regarding drug contamination and safety, thereby appealing to healthcare providers seeking reliable solutions. In September 2025, B. Braun Melsungen AG (DE) unveiled a partnership with a leading technology firm to integrate AI capabilities into its drug transfer systems. This collaboration is expected to enhance the functionality of their devices, allowing for real-time monitoring and data analytics, which could significantly improve patient outcomes and operational efficiency. In August 2025, Terumo Corporation (JP) expanded its manufacturing capabilities by investing in a new facility dedicated to producing closed system drug transfer devices. This investment not only signifies Terumo's commitment to meeting the increasing demand for safe drug handling but also positions the company to respond more effectively to market fluctuations and customer needs. As of November 2025, the competitive trends in the closed system-drug-transfer-device market are increasingly defined by digitalization, sustainability, and the integration of advanced technologies such as AI. Strategic alliances are becoming more prevalent, allowing companies to pool resources and expertise to drive innovation. The shift from price-based competition to a focus on technological differentiation and supply chain reliability is evident, suggesting that future competitive advantages will hinge on the ability to innovate and adapt to evolving market demands. ## Recent News & Developments Recent developments in the Japan Closed System Drug Transfer Device Market indicate significant advancements and focus on safety and efficiency in medical facilities. Companies like C.R. Bard, Baxter International, and West Pharmaceutical Services have been enhancing their product offerings to meet the growing demand for safety-engineered devices. Notably, in June 2023, Vygon announced a strategic collaboration with a leading Japanese pharmaceutical company to drive innovation in drug transfer safety, showcasing the increasing importance of local partnerships. Moreover, in July 2022, Thermo Fisher Scientific expanded its presence in Japan by opening a new facility focused on production innovations in drug delivery systems, reflecting the market's growth potential. In terms of mergers and acquisitions, there are reports of C.R. Bard considering strategic acquisitions to bolster its market share in Japan, although no specific transactions have been finalized as of October 2023. The increasing focus on patient safety regulations and the rising incidence of oncology treatments are contributing to the overall market valuation growth, positioning Japan as a pivotal region for investments in closed-system drug transfer technologies. The market is expected to continue evolving with the need for improved healthcare solutions. ## Report Scope | MARKET SIZE 2024 | 60.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 66.73(USD Million) | | MARKET SIZE 2035 | 193.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.21% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Baxter International Inc (US), B. Braun Melsungen AG (DE), Cardinal Health Inc (US), Cypress Medical Products LLC (US), ICU Medical Inc (US), Merit Medical Systems Inc (US), Pall Corporation (US), Terumo Corporation (JP) | | Segments Covered | Type, Component, Closing Mechanism, Technology, End User | | Key Market Opportunities | Growing demand for safety and efficiency in drug handling drives innovation in closed system-drug-transfer-device market. | | Key Market Dynamics | Rising regulatory scrutiny drives innovation and adoption of closed system-drug-transfer-devices in Japan's healthcare sector. | | Countries Covered | Japan | ## Frequently Asked Questions **Q: What was the market valuation of the Japan closed system-drug-transfer-device market in 2024?** A: The market valuation was $60.0 Million in 2024. **Q: What is the projected market valuation for the Japan closed system-drug-transfer-device market by 2035?** A: The projected valuation for 2035 is $193.0 Million. **Q: What is the expected CAGR for the Japan closed system-drug-transfer-device market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 11.21%. **Q: Which companies are considered key players in the Japan closed system-drug-transfer-device market?** A: Key players include Baxter International Inc, B. Braun Melsungen AG, Cardinal Health Inc, and others. **Q: What are the main types of closed system-drug-transfer devices in the market?** A: Main types include Membrane-To-Membrane Systems and Needleless Systems, with valuations of $20.0 Million and $40.0 Million respectively. **Q: What components are included in the Japan closed system-drug-transfer-device market?** A: Components include Vial Access Devices, Syringe Safety Devices, and others, with valuations ranging from $10.0 Million to $65.0 Million. **Q: What closing mechanisms are utilized in the Japan closed system-drug-transfer-device market?** A: Closing mechanisms include Push To Turn System and Luer Lock Systems, with valuations of $15.0 Million and $18.0 Million respectively. **Q: What technologies are employed in the Japan closed system-drug-transfer-device market?** A: Technologies include Compartmentalize Devices and Diaphragm-Based Devices, with valuations of $15.0 Million and $25.0 Million respectively. **Q: Who are the primary end users of closed system-drug-transfer devices in Japan?** A: Primary end users include hospitals & clinics and specialty centers, with valuations of $30.0 Million and $20.0 Million respectively. **Q: How does the market performance of closed system-drug-transfer devices vary by component?** A: Market performance varies, with Syringe Safety Devices valued at $65.0 Million and Accessories at $10.0 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/japan-closed-system-drug-transfer-device-market-49669*